SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.
Bolsa de Comercio de Buenos Aires
Börse Bolsa de Comercio de Buenos Aires
  • Johnson & Johnson
    Börse Börse Frankfurt
    ISIN US4781601046
    Symbol JNJ
    EUR
  • Johnson & Johnson
    Börse Börse Stuttgart
    Symbol JNJ
    EUR
  • Johnson & Johnson
    Börse Börse München
    Symbol JNJ
    EUR
  • Johnson & Johnson
    Börse Börse Berlin
    Symbol JNJ
    EUR
  • JOHNSON & JOHNSON
    Börse Xetra Frankfurt
    Symbol JNJ
    EUR
  • JOHNSON & JOHNSON
    Börse Gettex System der Börse München
    Symbol JNJ
    EUR
  • JOHNSON & JOHNSON
    Börse Tradegate System der Deutsche Börse AG (60%)
    Symbol JNJ
    EUR
  • JOHNSON & JOHNSON
    Börse Quotrix System der Börse Düsseldorf
    Symbol JNJ
    EUR
  • JOHNSON & JOHNSON
    Börse Börse Düsseldorf
    Symbol JNJ
    EUR
  • JOHNSON & JOHNSON
    Börse Börse Hamburg
    Symbol JNJ
    EUR
  • Johnson & Johnson
    Börse SGO
    USD
  • Johnson & Johnson
    Börse BUE
    USD
  • Johnson & Johnson
    Börse Bolsa de Comercio de Buenos Aires
  • Johnson & Johnson
    Börse Bolsa de Comercio de Buenos Aires
  • Johnson & Johnson
    Börse Bolsa de Comercio de Buenos Aires
  • Johnson & Johnson
    Börse Bolsa Mexicana de Valore Mexiko-Stadt
  • Johnson & Johnson
    Börse SSE
Marktkapitalisierung 99.567.000.000
Mitarbeiter 141.700

Analystenmeinungen

Übersicht

Aktionärsstruktur der Johnson & Johnson

2.760 News & Informationen zur Johnson & Johnson Aktie

  • Budweiser plugs Labor Day cans and New York Fashion Week begins: The Week Ahead
    adage.com

    Budweiser plugs Labor Day cans and New York Fashion Week begins: The Week Ahead

    Marketing and media events to watch in the next seven days.

  • When Can You Get A Covid-19 Booster Shot?
    forbes.com

    When Can You Get A Covid-19 Booster Shot?

    Exactly what the booster shot plan will look like still depends on the FDA and CDC and the results of ongoing studies.

  • Fauci says it's likely only Pfizer vaccine will be used at outset of booster campaign
    businessinsider.com

  • $26-B opioid lawsuits deal to move ahead
    manilatimes.net

  • The best 9.9 beauty deals
    businessmirror.com.ph

    The best 9.9 beauty deals

    THE two-number sales on e-commerce platforms such as Lazada and Shopee offer good bargains on everything, from laundry detergent to shoes and apparel. You can also get bonus discount vouchers, additional discounts and other perks and privileges. One of the best things to buy in these sales are makeup and…

  • $26 billion opioid settlement ready for next step: US drug firms
    livemint.com

    $26 billion opioid settlement ready for next step: US drug firms

    Four pharmaceutical companies have said they received enough support from US states to move to the next stage of a $26 billion settlement over thousands of legal claims related to the opioid epidemic

  • Covid-19 India Updates: New Cases Exceed Daily Recoveries For Fifth Straight Day
    bloombergquint.com

    Covid-19 India Updates: New Cases Exceed Daily Recoveries For Fifth Straight Day

    Follow the latest updates on the Covid-19 pandemic in India here.

  • Opioid Distributors to Move Forward With $26 Billion Accord
    bloombergquint.com

    Opioid Distributors to Move Forward With $26 Billion Accord

    (Bloomberg) — McKesson Corp. and two other opioid distributors agreed Saturday to press ahead with their part of a $26 billion settlement aimed at resolving thousands of state and local government lawsuits over their alleged mishandling of the addictive painkillers.McKesson, Cardinal Health Inc.

  • Drug companies say enough U.S. states join $26 bln opioid settlement to proceed
    financialpost.com

    Drug companies say enough U.S. states join $26 bln opioid settlement to proceed

    Three large U.S. drug distributors and drugmaker Johnson & Johnson will proceed with a proposed $26 billion settlement resolving claims that they fueled the…

  • Only those fully vaccinated allowed to work in Johor manufacturing sector
    thesundaily.my

    Only those fully vaccinated allowed to work in Johor manufacturing sector

    JOHOR BAHRU: Only individuals who have completed the 28-day or 14-day window after one-dose or two-dose vaccination, respectively, will be allowed to …

  • Drug companies say enough U.S. states join $26 billion opioid settlement to proceed
    oann.com

    Drug companies say enough U.S. states join $26 billion opioid settlement to proceed

    Breaking News, Latest News and Current News from OANN.com. Breaking news and video. Latest Current News: U.S., World, Entertainment, Health, Business, Technology, Politics, Sports.

  • Drug companies say enough U.S. states join $26 billion opioid settlement to proceed By Reuters
    investing.com

    Drug companies say enough U.S. states join $26 billion opioid settlement to proceed By Reuters

    Drug companies say enough U.S. states join $26 billion opioid settlement to proceed

  • Johnson & Johnson, three drug distributors say “enough” states back opioid deal - Reuters
    markets.businessinsider.com

    Johnson & Johnson, three drug distributors say “enough” states back opioid deal – Reuters

    Johnson & Johnson (JNJ) and three major drug distributors will move forward with a previously announced $26B settlement over allegations that they helped fuel the nation’s opioid…

  • U.S. administers 374.5 million doses of COVID-19 vaccines -CDC By Reuters
    investing.com

    U.S. administers 374.5 million doses of COVID-19 vaccines -CDC By Reuters

    U.S. administers 374.5 million doses of COVID-19 vaccines -CDC

  • Investors care more about fair wages for workers than environmental issues, ESG survey shows
    marketwatch.com

    Investors care more about fair wages for workers than environmental issues, ESG survey shows

    Plus, four funds that screen for positive treatment of employees or fair labor practices.

  • COVID-19 | US health officials advise White House to scale back booster plan for now
    moneycontrol.com

    COVID-19 | US health officials advise White House to scale back booster plan for now

    Narrowing the booster plan could confuse the public and create a perception that federal vaccine policy is in some degree of disarray. But some public health experts will most likely welcome it.

  • U.S. COVID-19 booster shot campaign to start with only Pfizer - source
    financialpost.com

    U.S. COVID-19 booster shot campaign to start with only Pfizer – source

    WASHINGTON — A White House plan to offer COVID-19 booster shots will most likely start this month only with the vaccine made by Pfizer Inc and BioNTech , a…

  • Zehnjahresbilanz: Welche Themenfonds über Jahre hohe Gewinne abwerfen
    finanzen.net

    Zehnjahresbilanz: Welche Themenfonds über Jahre hohe Gewinne abwerfen

    Einzelne Wirtschaftszweige haben Anlegern langfristig hohe Gewinne beschert. Welche Fonds in den vergangenen 10 Jahren besonders glänzten, wo sich der Einstieg lohnt. 04.09.2021

  • Staying power: does Moderna’s vaccine have edge on Pfizer?
    ft.com

    Staying power: does Moderna’s vaccine have edge on Pfizer?

    Studies suggest stronger immune response than its mRNA rival and it wanes more slowly

  • Association of American Physicians and Surgeons (AAPS) Asks Pima County Supervisors to Reject COVID-19 Vaccine Mandate
    globenewswire.com

    Association of American Physicians and Surgeons (AAPS) Asks Pima County Supervisors to Reject COVID-19 Vaccine Mandate

    TUCSON, Ariz., Sept. 03, 2021 (GLOBE NEWSWIRE) — On Sept 7, the Pima County Board of Supervisors will consider a proposal to mandate that all healthcare…

  • The Fall Forecast for Stocks Is Gloomy. How to Navigate a Challenging Market
    marketwatch.com

    The Fall Forecast for Stocks Is Gloomy. How to Navigate a Challenging Market

    Our panel sees muted gains for stocks as the Fed starts to taper and earnings growth peaks. Stick with quality companies—and keep an eye on rising bond yields.

  • Covid-19 Vaccine Booster Launch Could Be Delayed for Many
    online.wsj.com

    Covid-19 Vaccine Booster Launch Could Be Delayed for Many

    Federal health officials are asking the White House to push back the start of a planned booster campaign, at least for the Moderna and Johnson & Johnson vaccines, people familiar with the discussions said.

  • Omnicom : Maggie Garrison joins DDB Worldwide as Associate Director, Communications and Marianna Eboli is promoted to Global Social Media...
    marketscreener.com

    Omnicom : Maggie Garrison joins DDB Worldwide as Associate Director, Communications and Marianna Eboli is promoted to Global Social Media Manager

    NEW YORK, Sept. 3, 2021 /PRNewswire/ — DDB Worldwide has today announced that Maggie Garrison has joined the global advertising network as Associate Director, Communications. Garrison joins… | September 3, 2021

  • DCGI nod to phase-I clinical trial of Reliance Life Sciences' Covid vaccine
    business-standard.com

    DCGI nod to phase-I clinical trial of Reliance Life Sciences' Covid vaccine

    Read more about DCGI nod to phase-I clinical trial of Reliance Life Sciences' Covid vaccine on Business Standard. DCGI on Friday granted permission to the Mukesh Ambani-owned Reliance Life Sciences to conduct phase-I clinical trial of its indigenous COVID-19 vaccine with certain conditions, sources said.

  • Travel Advisory: REMINDER - On September 7, new measures for fully vaccinated international travellers to Canada will come into force
    prnewswire.com

    Travel Advisory: REMINDER – On September 7, new measures for fully vaccinated international travellers to Canada will come into force

    /PRNewswire/ – As was announced on July 19, the Government of Canada will allow fully vaccinated foreign nationals meeting the conditions to enter Canada for…

  • DCGI nod to phase-I clinical trial of COVID-19 vaccine of Reliance Life Sciences
    economictimes.indiatimes.com

    DCGI nod to phase-I clinical trial of COVID-19 vaccine of Reliance Life Sciences

    The firm is required to submit the revised clinical trial protocol for immunogenicity to be assessed on Day 42, instead of Day 14, as recommended by the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation, a source said, citing the conditions set for the trial.

  • Reliance gets DCGI nod to conduct phase-I clinical trial of Covid-19 vaccine
    livemint.com

    Reliance gets DCGI nod to conduct phase-I clinical trial of Covid-19 vaccine

    The phase-I clinical trial will be conducted to evaluate safety, tolerability and immunogenicity of the SARS-CoV-2 recombinant protein subunit vaccine in healthy volunteers according to protocol

  • Insider Buying at These Biotech Firms Indicates Value
    gurufocus.com

    Insider Buying at These Biotech Firms Indicates Value

    GuruFocus Article or News written by Praveen Chawla and the topic is about: Significant insider buying at or near 52-week lows highlights these stocks as good opportunities

  • Insider Buying at These Biotech Companies Indicates Value
    gurufocus.com

    Insider Buying at These Biotech Companies Indicates Value

    GuruFocus Article or News written by Praveen Chawla and the topic is about: Significant insider buying at or near 52-week lows highlights these stocks as good opportunities

  • Vaccine deaths in Mindanao?
    manilatimes.net

  • The leaders of the FDA and CDC are reportedly pushing back on Biden's booster-shot plan, saying they need more time and data
    businessinsider.com

    The leaders of the FDA and CDC are reportedly pushing back on Biden's booster-shot plan, saying they need more time and data

    Leading health officials told the White House they need more time to review booster data, The New York Times reported.

  • WOCHENVORSCHAU: Termine bis 17. September 2021
    finanzen.net

    WOCHENVORSCHAU: Termine bis 17. September 2021

    WOCHENVORSCHAU: Termine bis 17. September 2021 | Nachricht | finanzen.net

  • Global Industry Analysts Predicts The World Bioimplants Market To Reach $127.8 Billion By 2026
    thestreet.com

    Global Industry Analysts Predicts The World Bioimplants Market To Reach $127.8 Billion By 2026

    SAN FRANCISCO, Sept. 3, 2021 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today

  • 10 Best-Performing Countries for COVID-19 Vaccinations
    insidermonkey.com

    10 Best-Performing Countries for COVID-19 Vaccinations

    In this article, we will list the 10 best-performing countries for COVID-19 vaccinations.

  • Investing In The Dividend Aristocrats From 2011
    valuewalk.com

    Investing In The Dividend Aristocrats From 2011

    The Dividend Aristocrats index includes companies that are members of S&P 500, which have managed to raise dividends annually

  • Some Claim Covid-19 Vaccine Is Not A Vaccine, Twitter Suspends Alex Berenson’s Account
    forbes.com

    Some Claim Covid-19 Vaccine Is Not A Vaccine, Twitter Suspends Alex Berenson’s Account

    Writer Alex Berenson recently tweeted out the following about the Covid-19 vaccines: “don’t think of it as a vaccine.”

  • What’s New With Novavax Stock?
    forbes.com

    What’s New With Novavax Stock?

    Novavax stock rallied by about 5% over the last week, outperforming the S&P 500 which gained less than 1% over the same period. Although Novavax doesn’t have a revenue-generating product just yet, with the company intending to file for Emergency Use Authorization for its Covid-19 vaccine in the U.K.

  • PHC Holdings Corporation: Appointment of Mr. William Donnelly and Mr. Ivan Tornos as Independent External Directors
    financialpost.com

    PHC Holdings Corporation: Appointment of Mr. William Donnelly and Mr. Ivan Tornos as Independent External Directors

    TOKYO — PHC Holdings Corporation (headquarters: Minato-ku, Tokyo, Japan, President & CEO: John Marotta, hereafter PHCHD), a leading global life science,…

  • AstraZeneca reaches settlement with EU on COVID-19 vaccine delivery
    financialpost.com

    AstraZeneca reaches settlement with EU on COVID-19 vaccine delivery

    AstraZeneca and the European Commission and have reached a settlement on the delivery of pending COVID-19 vaccine doses by the drugmaker, ending a row about…

  • 5 important things happening in South Africa today
    businesstech.co.za

    5 important things happening in South Africa today

    Mandatory vaccination policies already seeing some backlash; the EU is returning millions of vaccine doses so they can be redistributed in Africa; parliament…

Schreibe einen Kommentar

Wenn du schon einen Account hast, logge dich ein bevor du den Kommentar absendest.

Galue Account Vorteile
  • Battles

    Messe dich mit der Community in Battles.

  • Badges

    Erhalte Belohnungen für Kommentare, die der Community helfen.

  • Mehr Informationen für alle

    Poste Bilder oder Videos zu Themen und Unternehmen und helf dabei, dass Investoren ein kontroverseres Bild erhalten.

  • Kein Datenrisiko

    Du kannst jederzeit deinen Account löschen und gespeicherte Daten einsehen.

Portrait der Johnson & Johnson Aktie

Das Unternehmen Johnson & Johnson aus USA beschäftigt 141.700 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Medizinische Produkte / Medizintechnik, Drogerie & Kosmetik, Biotechnologie, Pharma tätig.

Johnson & Johnson ist in ungefähr 18 ETFs enthalten und somit eine nicht sonderlich bekannte oder beliebte Aktie. Der Spitzenreiter UBS ETF (IE) Factor  MSCI USA  Quality  UCITS  ETF (hedged to CHF) A-acc gewichtet Johnson & Johnson mit 4,34% im ETF.

Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Johnson & Johnson Anleihen auf einen Blick.

Entdecke die 6 ETFs in denen Johnson & Johnson am höchsten gewichtet ist Insgesamt in 18 ETFs enthalten

Dir gefallen die Informationen zu Johnson & Johnson?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:

Zur Comdirect

Dir gefallen die Informationen zu Johnson & Johnson?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:

Zu BUX Zero

Dir gefallen die Informationen zu Johnson & Johnson?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:

Zu Trade Republic

Dir gefallen die Informationen zu Johnson & Johnson?

Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:

Zur ING Diba